Medicine

Members of Pennsylvania’s Medical Marijuana Advisory Board are publicly questioning the Wolf administration’s oversight of doctors and third-party certification companies.

Pediatric cases of RSV and flu have sent families crowding into ERs, as health systems struggle with staff shortages.

Drug maker Emergent BioSolutions is seeking approval from the Food and Drug Administration to sell Narcan over the counter, without need for a prescription.

Nursing homes leaders are redoubling efforts to get staff and residents boosted with the new version of the COVID-19 vaccine.

A new study, led by a Rutgers researcher, found that buprenorphine, rather than methadone, may be safer for infants born to mothers getting treatment for opioid use disorder.

Just under 14% of Pennsylvanians, age five or older, have gotten the shot, according to data from the Centers for Disease Control and Prevention.

The Food and Drug Administration estimates that around 30 million people in the United States deal with hearing loss.

If you stroll the cold and flu medicine aisle these days, you might notice shelves that are bare, or nearly so.

Influenza activity in Philadelphia has rapidly increased over the past few weeks. Health providers expect even more cases following the holidays.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

"Removing 'monkey' removes the stigma that monkeypox comes with," an expert tells NPR. But he questions why the World Health Organization will wait a year to make the change.

“Stop The Bleed” teaches emergency responsiveness, and many Philadelphians are training to combat gunshot wounds.

Patient advocates are trying to address the disparities people of color face while trying to get a migraine diagnosis or treatment.

Some credit cards advertised by hospitals lure in patients with promises of convenient, low-interest payments on big bills. But interest rates soar if you can't pay quickly.

Children under 5 years old are the last remaining group of people who are not yet eligible for COVID-19 bivalent vaccines.